|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,338.00 JPY | +1.61% |
|
-4.86% | +7.62% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,081B 6.86B 5.94B 5.54B 5.1B 9.62B 652B 9.73B 65.1B 25.55B 326B 25.77B 25.2B | P/E 2027 * |
15.1x | P/E 2028 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 881B 5.59B 4.84B 4.51B 4.15B 7.84B 532B 7.92B 53.04B 20.82B 266B 21B 20.53B | EV / Sales 2027 * |
1.94x | EV / Sales 2028 * | 1.87x |
| Free-Float |
80.98% | Yield 2027 * |
3.41% | Yield 2028 * | 3.37% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +1.61% | ||
| 1 week | -4.86% | ||
| Current month | -1.93% | ||
| 1 month | -4.51% | ||
| 3 months | -0.95% | ||
| 6 months | -5.90% | ||
| Current year | +7.62% |
| 1 week | 2,264.5 |  | 2,408.5 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.61% | -4.86% | +36.73% | -14.17% | 6.86B | |
| +0.79% | -2.29% | +22.57% | +68.44% | 48.95B | |
| +3.09% | +7.65% | +60.81% | +132.38% | 39.36B | |
| +1.33% | +0.80% | -0.58% | +20.79% | 12.39B | |
| -1.37% | -0.82% | +18.58% | +68.80% | 11.76B | |
| 0.00% | -0.38% | +30.75% | +134.53% | 9.14B | |
| -0.17% | +3.07% | +18.28% | +33.85% | 7.05B | |
| +0.50% | +3.70% | +12.13% | +178.36% | 6.7B | |
| +0.79% | +3.84% | -29.57% | +15.81% | 5.67B | |
| +1.12% | +1.16% | +36.79% | +99.13% | 4.51B | |
| Average | +0.78% | -0.11% | +20.65% | +73.79% | 15.24B | |
| Weighted average by Cap. | +1.21% | -0.28% | +29.21% | +83.54% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.89B 2.5B 2.33B 2.14B 4.04B 274B 4.09B 27.38B 10.74B 137B 10.84B 10.6B | 445B 2.82B 2.44B 2.28B 2.1B 3.96B 268B 4B 26.77B 10.51B 134B 10.6B 10.36B |
| Net income | 71.42B 453M 393M 366M 337M 635M 43.1B 642M 4.3B 1.69B 21.56B 1.7B 1.66B | 62.78B 398M 345M 322M 296M 559M 37.88B 565M 3.78B 1.48B 18.96B 1.5B 1.46B |
| Net Debt | -200B -1.27B -1.1B -1.03B -944M -1.78B -121B -1.8B -12.07B -4.74B -60.51B -4.78B -4.67B | -248B -1.58B -1.36B -1.27B -1.17B -2.21B -150B -2.23B -14.94B -5.87B -74.94B -5.92B -5.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | JP¥2,338.00 | +1.61% | 1,513,200 |
| 26-08-05 | JP¥2,301.00 | -0.26% | 1,636,100 |
| 26-08-04 | JP¥2,307.00 | -1.30% | 2,047,600 |
| 26-08-03 | JP¥2,337.50 | -1.95% | 1,775,600 |
| 26-07-31 | JP¥2,384.00 | -2.99% | 3,274,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
